14
N. Vasdev et al. / Journal of Fluorine Chemistry 121 (2003) 9–14
purification step. The TFA was evaporated and the sample
was redissolved in 0.1% HOAc and used for characteriza-
tion. Preparative HPLC conditions used for the products of
fluorination of 3-nitro-L-tyrosine and for the study of the
relative reactivity of [18F]F2 towards L-tyrosine and 3-nitro-
L-tyrosine were identical to those described above except
that the mobile phase was an aqueous solution comprised
of 20% CH3CN and 0.1% TFA. Under these conditions,
L-tyrosine eluted at 8.5 min and [18F]FNT eluted at 9.5 min.
Aliquots of the reaction mixture and of purified [18F]FNT
were analyzed on a reverse-phase HPLC column (Phenom-
enex, ODS-2, 0:9 cm ꢂ 25 cm) and an aqueous solution of
20% CH3CN with 0.1% TFA as the mobile phase using a
flow rate of 3.0 mL minꢁ1. Under these conditions, 3-fluoro-
L-tyrosine and [18F]FNT eluted at 5.5 and 7.5 min, respec-
tively. The identity of the peak eluting at 5.5 min was
confirmed by spiking the reaction mixture with 3-fluoro-
DL-tyrosine. The eluate from the column was passed through
a Waters 490E programmable multiwavelength UV detector
(275 nm) and a Beckman radioisotope detector (Model 170).
Both detectors were connected to a Waters Millennium
Chromatography Manager.
(N.V.) and for support in the form of a research grant (G.J.S.).
We also thank Dr. Russell A. Bell and Dr. Frank J. Laronde for
helpful discussions.
References
[1] G.A. Olah, R. Malhotra, S.C. Narang, Nitration: Methods and
Mechanisms, VCH Publishers, New York, 1989, pp. 1–311.
[2] J.G. Hoggett, R.B. Moodie, J.R. Penton, K. Schofield, Nitration and
Aromatic Reactivity, Cambridge University Press, Cambridge, 1971,
pp. 1–230.
[3] B. Halliwell, FEBS Lett. 411 (1997) 157–160.
[4] J.K. Hurst, J. Clin. Invest. 109 (2002) 1287–1289.
[5] H. Ischiropoulos, Arch. Biochem. Biophys. 356 (1998) 1–11.
[6] C. Herce-Pagliai, S. Kotescha, D.E.G. Shuker, Nitric Oxide 2 (1998)
324–336.
[7] W. Skawinski, J. Flisak, A.C. Chung, F. Jordan, R. Mendelsohn, J.
Labelled Compd. Radiopharm. 28 (1990) 1179–1183.
[8] W.J. Skawinski, F. Adebodun, J.T. Cheng, F. Jordan, R. Mendelsohn,
Biochim. Biophys. Acta 1162 (1993) 297–308.
[9] G.A. Olah, R. Malhotra, S.C. Narang, Nitration: Methods and
Mechanisms, VCH Publishers, New York, 1989, pp. 9–83.
[10] R.D. Chambers, C.J. Skinner, UK Patent 2 291 871 (1996).
[11] G. Firnau, R. Chirakal, E.S. Garnett, J. Nucl. Med. 25 (1984) 1228–
1233.
[12] R. Chirakal, K.L. Brown, G. Firnau, E.S. Garnett, D.W. Hughes,
B.G. Sayer, R.W. Smith, J. Fluorine Chem. 37 (1987) 267–
278.
4.2. Nuclear magnetic resonance spectroscopy
Proton 13C and 19F NMR spectra were recorded on a
Bruker Avance 200 spectrometer and referenced at 30 8C to
external Me4Si, Me4Si and CFCl3, respectively, and were
acquired at 200.200, 50.328 and 188.376 MHz, respectively.
All spectra were recorded unlocked and without spinning the
samples. Proton spectra were obtained in eight scans, in
16 K memories over 4.1 kHz spectral widths corresponding
to an acquisition time of 2.02 s and a resolution of 0.25 Hz/
data point. Carbon-13 spectra were obtained in 25,000 scans,
in 16 K memories over 12.6 kHz spectral widths corre-
sponding to an acquisition time of 0.652 s and a resolution
of 0.77 Hz/data point. Fluorine-19 spectra were obtained in
300 scans, in 32 K memories over 17.4 kHz spectral widths
corresponding to an acquisition time of 0.939 s and a
resolution of 0.53 Hz/data point.
¨
[13] H.H. Coenen, K. Franken, P. Kling, G. Stocklin, Appl. Radiat. Isot.
39 (1988) 1243–1250.
[14] R. Chirakal, G. Firnau, E.S. Garnett, J. Nucl. Med. 27 (1986)
417–421.
[15] R. Chirakal, G.J. Schrobilgen, G. Firnau, S. Garnett, Appl. Radiat.
Isot. 42 (1991) 113–119.
[16] R. Chirakal, N. Vasdev, G.J. Schrobilgen, C. Nahmias, J. Fluorine
Chem. 99 (1999) 87–94.
[17] N. Vasdev, R. Chirakal, G.J. Schrobilgen, C. Nahmias, J. Fluorine
Chem. 111 (2001) 17–25.
[18] G. Firnau, S. Sood, R. Pantel, S. Garnett, Mol. Pharmacol. 19 (1981)
130–133.
[19] F. Cacace, A.P. Wolf, J. Am. Chem. Soc. 100 (1978) 3639–
3641.
[20] C. Lemaire, Fluorine-l 8 labeling of radiopharmaceuticals for PET
studies: main aspects and problems encountered in chemical syntheses,
in: A.M. Emran (Ed.), Chemists’ Views of Imaging Centers, Plenum
Press, New York, 1995, pp. 367–382.
[21] F. Reinhardt, W.G. Hume, A.L. Linch, J.M. Wetherhold, J. Chem.
Ed. 46 (1969) A171–A179.
Acknowledgements
[22] Peters, R. Miethchen, J. Fluorine Chem. 79 (1996) 161–165.
[23] B. Segal, Chem. Health Saf. 7 (2000) 18–23.
[24] Kalinowski, S. Berger, S. Braun, Carbon-13 NMR Spectroscopy,
Wiley, New York, 1988, p. 321.
We thank the Natural Sciences and Engineering Research
Council ofCanada forthe award of a postgraduate scholarship